Co-Authors
This is a "connection" page, showing publications co-authored by Marilyn Kwan and Mai Nguyen-Huynh.
Connection Strength
1.723
-
Racial and Ethnic Disparities in Risk of Cardiovascular Disease in Women Treated for Breast Cancer. medRxiv. 2026 Apr 24.
Score: 0.244
-
Diet quality and cardiometabolic health in breast cancer survivors: the Pathways Study. Breast Cancer Res Treat. 2025 Feb 01.
Score: 0.224
-
Adherence to cardiovascular medications and risk of cardiovascular disease in breast cancer patients: A causal inference approach in the Pathways Heart Study. PLoS One. 2024; 19(9):e0310531.
Score: 0.219
-
Diet quality and cardiovascular disease risk among breast cancer survivors in the Pathways Study. JNCI Cancer Spectr. 2024 Feb 29; 8(2).
Score: 0.210
-
Reply to M.S. Ewer et al. J Clin Oncol. 2022 Jul 25; JCO2201353.
Score: 0.188
-
Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study. J Clin Oncol. 2022 May 20; 40(15):1647-1658.
Score: 0.184
-
Risk of Cardiometabolic Risk Factors in Women With and Without a History of Breast Cancer: The Pathways Heart Study. J Clin Oncol. 2022 Jan 13; JCO2101738.
Score: 0.181
-
Polygenic Risk for Cardiometabolic and Cardiovascular Disease in a Multiethnic Cohort of Breast Cancer Survivors. JACC CardioOncol. 2026 Feb; 8(1):65-76.
Score: 0.060
-
Endocrine therapy and risk of cardiovascular disease and mortality in postmenopausal breast cancer survivors. J Natl Cancer Inst. 2025 Mar 11.
Score: 0.056
-
Duration of aromatase inhibitor use and long-term cardiovascular risk in breast cancer survivors. JNCI Cancer Spectr. 2025 Jan 28.
Score: 0.056
-
Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer. Breast Cancer Res Treat. 2023 Aug; 201(1):117-126.
Score: 0.050
-
Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer. Res Sq. 2023 Mar 22.
Score: 0.049